NCT04140578 Antibiotic Prophylaxis in Patients Undergoing GVO
| NCT ID | NCT04140578 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Taipei Veterans General Hospital, Taiwan |
| Condition | Gastric Varix |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2017-01-28 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 150 participants in total. It began in 2017-01-28 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.
Eligibility Criteria
Inclusion Criteria: 1. Patients with live cirrhosis and/or hepatoma 2. Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV Exclusion Criteria: 1. Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD 2. Patients recieve antibiotics recently. 3. Patients suspected infection.
Contact & Investigator
Ming-Chih Hou
PRINCIPAL INVESTIGATOR
Taipei Veterans General Hospital, Taiwan
Frequently Asked Questions
Who can join the NCT04140578 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 85 Years, studying Gastric Varix. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04140578 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT04140578 currently recruiting?
Yes, NCT04140578 is actively recruiting participants. Contact the research team at mchou@vghtpe.gov.tw for enrollment information.
Where is the NCT04140578 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT04140578 clinical trial?
NCT04140578 is sponsored by Taipei Veterans General Hospital, Taiwan. The principal investigator is Ming-Chih Hou at Taipei Veterans General Hospital, Taiwan. The trial plans to enroll 150 participants.